UAE says Sinopharm vaccine has 86% efficacy against Covid-19 | The Business Standard
Skip to main content
  • Epaper
  • Economy
    • Aviation
    • Banking
    • Bazaar
    • Budget
    • Industry
    • NBR
    • RMG
    • Corporates
  • Stocks
  • Analysis
  • Videos
    • TBS Today
    • TBS Stories
    • TBS World
    • News of the day
    • TBS Programs
    • Podcast
    • Editor's Pick
  • World+Biz
  • Features
    • Panorama
    • The Big Picture
    • Pursuit
    • Habitat
    • Thoughts
    • Splash
    • Mode
    • Tech
    • Explorer
    • Brands
    • In Focus
    • Book Review
    • Earth
    • Food
    • Luxury
    • Wheels
  • Subscribe
    • Epaper
    • GOVT. Ad
  • More
    • Sports
    • TBS Graduates
    • Bangladesh
    • Supplement
    • Infograph
    • Archive
    • Gallery
    • Long Read
    • Interviews
    • Offbeat
    • Magazine
    • Climate Change
    • Health
    • Cartoons
  • বাংলা
The Business Standard

Thursday
May 29, 2025

Sign In
Subscribe
  • Epaper
  • Economy
    • Aviation
    • Banking
    • Bazaar
    • Budget
    • Industry
    • NBR
    • RMG
    • Corporates
  • Stocks
  • Analysis
  • Videos
    • TBS Today
    • TBS Stories
    • TBS World
    • News of the day
    • TBS Programs
    • Podcast
    • Editor's Pick
  • World+Biz
  • Features
    • Panorama
    • The Big Picture
    • Pursuit
    • Habitat
    • Thoughts
    • Splash
    • Mode
    • Tech
    • Explorer
    • Brands
    • In Focus
    • Book Review
    • Earth
    • Food
    • Luxury
    • Wheels
  • Subscribe
    • Epaper
    • GOVT. Ad
  • More
    • Sports
    • TBS Graduates
    • Bangladesh
    • Supplement
    • Infograph
    • Archive
    • Gallery
    • Long Read
    • Interviews
    • Offbeat
    • Magazine
    • Climate Change
    • Health
    • Cartoons
  • বাংলা
THURSDAY, MAY 29, 2025
UAE says Sinopharm vaccine has 86% efficacy against Covid-19

Coronavirus chronicle

Reuters
09 December, 2020, 12:50 pm
Last modified: 09 December, 2020, 02:06 pm

Related News

  • UAE tops 50c in highest May temperature on record
  • What is Al-Ayyala dance that welcomed Trump in Abu Dhabi?
  • Pakistan's T20 cricket league moved to UAE over India conflict
  • World court dismisses Sudan's genocide case against UAE over alleged Darfur interference
  • UAE expedites visa issuance for Bangladeshis following talks

UAE says Sinopharm vaccine has 86% efficacy against Covid-19

The analysis also shows 99% seroconversion rate of neutralizing antibody and 100% effectiveness in preventing moderate and severe cases of the disease

Reuters
09 December, 2020, 12:50 pm
Last modified: 09 December, 2020, 02:06 pm
Woman holds vials labelled "Covid-19 Coronavirus Vaccine" over dry ice in this illustration taken, 5 December, 2020/ Reuters
Woman holds vials labelled "Covid-19 Coronavirus Vaccine" over dry ice in this illustration taken, 5 December, 2020/ Reuters

An experimental coronavirus vaccine developed by China's Sinopharm has 86% efficacy against the virus, the United Arab Emirates health ministry said on Wednesday, citing an interim analysis of a human trial underway there.

The Gulf Arab state in July started Phase 3 clinical trials of the vaccine, developed by Beijing Institute of Biological Product, a unit of Sinopharm's China National Biotec Group (CNBG). In September, the UAE approved its emergency use for certain groups.

The analysis also shows "99% seroconversion rate of neutralizing antibody and 100% effectiveness in preventing moderate and severe cases of the disease", the ministry said in a statement carried by the state news agency.

The Business Standard Google News Keep updated, follow The Business Standard's Google news channel

"The analysis shows no serious safety concerns," it said.

It also said it had officially registered the vaccine, without elaborating, and that 31,000 volunteers across 125 nationalities participated in the UAE trial.

It did not say what side effects or illnesses participants experienced or how many volunteers were given the vaccine and how many received a placebo.

CNBG could not be immediately reached for comment.

The vaccine, which uses an inactivated virus unable to replicate human cells to trigger immune responses, requires two doses, past trial data has showed.

The UAE trial is a partnership between Sinopharm's CNBG, Abu Dhabi-based artificial intelligence company Group 42 (G42) and the Abu Dhabi Department of Health.

Sinopharm and G42 have also expanded the trial to Egypt, Jordan and Bahrain.

Abu Dhabi, the UAE's capital, this week said it was seeking volunteers to take part in clinical trials of Russia's COVID-19 vaccine, known as Sputnik V.

The UAE, with a population of around 9 million, has recorded 178,837 infections and 596 deaths from the disease.

Top News / World+Biz

Sinopharm vaccine / UAE / covid-19 vaccine

Comments

While most comments will be posted if they are on-topic and not abusive, moderation decisions are subjective. Published comments are readers’ own views and The Business Standard does not endorse any of the readers’ comments.

Top Stories

  • BNP Chairperson Khaleda Zia virtually addressing an event on 29 May 2025, marking the death anniversary of BNP founder and former president Ziaur Rahman. Photo: Screengrab from BNP Media Cell video.
    Democracy still being obstructed at every step: Khaleda Zia
  • Illustration: TBS
    Bangladesh repays $3.5b debt in 10 months of FY25
  • Ishraque Hossain speaks to reporters at Nagar Bhaban. on 29 May 2025. Photo: Md Jahidul Islam/TBS
    Oath immediately or tougher movement from tomorrow: Ishraque

MOST VIEWED

  • Dhaka areas at a gridlock on Wednesday, 28 May 2025. Photo: Syed Zakir Hossain/TBS
    BNP, Jamaat rallies: Traffic clogs Dhaka roads, including Motijheel, Paltan, Dainik Bangla intersection
  • IFIC Bank receives Tk6,000 cr in new deposits in six months
    IFIC Bank receives Tk6,000 cr in new deposits in six months
  • Mohammad Abdul Mannan, chairman FSIB Ltd. Sketch: TBS
    FSIB to bounce back soon
  • Abdul Awal Mintoo, chairman of National Bank Limited. Sketch: TBS
    'Regulatory support must for National Bank to restore depositors' confidence'
  • Md Nazrul Islam Swapan, chairman of EXIM Bank. Sketch: TBS
    Exim Bank restored depositors’ confidence, overcoming challenges
  • Mohammad Mamdudur Rashid, managing director and CEO, UCB. Sketch: TBS
    Customers’ trust and confidence fueling deposit growth at UCB

Related News

  • UAE tops 50c in highest May temperature on record
  • What is Al-Ayyala dance that welcomed Trump in Abu Dhabi?
  • Pakistan's T20 cricket league moved to UAE over India conflict
  • World court dismisses Sudan's genocide case against UAE over alleged Darfur interference
  • UAE expedites visa issuance for Bangladeshis following talks

Features

The university will be OK. But will the US? Photo: Bloomberg

A weaker Harvard is a weaker America

18m | Panorama
The Botanical Garden is a refuge for plant species, both native and exotic. Photo: Mehedi Hasan/TBS

The hidden cost of 'development' in the Botanical Garden

23m | Panorama
Stillbirths in Bangladesh: A preventable public health emergency

Stillbirths in Bangladesh: A preventable public health emergency

28m | Panorama
In recent years, the Gor-e-Shaheed Eidgah has emerged as a strong contender for the crown of the biggest Eid congregation in the country, having hosted 600,000 worshippers in 2017. Photo: TBS

Gor-e-Shaheed Boro Maath: The heart of Dinajpur

2d | Panorama

More Videos from TBS

Businesses set for relief as interim govt eyes major tax & fine cuts

Businesses set for relief as interim govt eyes major tax & fine cuts

2h | TBS Insight
Love is essential for human life

Love is essential for human life

1h | TBS Programs
What Should Be the Interim Government’s Budget Priority?

What Should Be the Interim Government’s Budget Priority?

28m | TBS Economy
Trying to organize free and fair elections: Dr. Yunus

Trying to organize free and fair elections: Dr. Yunus

3h | TBS Today
EMAIL US
contact@tbsnews.net
FOLLOW US
WHATSAPP
+880 1847416158
The Business Standard
  • About Us
  • Contact us
  • Sitemap
  • Advertisement
  • Privacy Policy
  • Comment Policy
Copyright © 2025
The Business Standard All rights reserved
Technical Partner: RSI Lab

Contact Us

The Business Standard

Main Office -4/A, Eskaton Garden, Dhaka- 1000

Phone: +8801847 416158 - 59

Send Opinion articles to - oped.tbs@gmail.com

For advertisement- sales@tbsnews.net